Show Categories

Platelet Activating GPCR Signaling

Click on one of the choices in the Explore Pathways box to view a different Platelet pathway.

alpha-2 Adrenergic R
P2Y12
alpha-2 Adrenergic R
P2Y12
Lyn
Lyn
Fyn
Fyn
G alpha i
G alpha i
Adenylyl Cyclase
Adenylyl Cyclase
cAMP
cAMP
PKA
PKA
Granule
Release
Granule
Release
ProductsClose
PAR1,3,4
Thromboxane A2 R
PAR1,3,4
Thromboxane A2 R
Fyn
Fyn
G alpha 12,13
G alpha 12,13
G alpha q
G alpha q
p115 RhoGEF
p115 RhoGEF
ProductsClose
RhoA
RhoA
ProductsClose
Granule
Release
Granule
Release
ProductsClose
ROCK
ROCK
Myosin LC
Phosphatase
Myosin LC
Phosphatase
PLC-beta
PLC-beta
PLC-gamma
PLC-gamma
IP3
IP3
DAG
DAG
Calcium Release
Calcium Release
ProductsClose
PKC alpha
PKC beta
PKC alpha
PKC beta
CalDAG-GEFI
CalDAG-GEFI
Granule
Release
Granule
Release
ProductsClose
Rap1B
Rap1B
RIAM
RIAM
Integrin
Activation
Integrin
Activation
ProductsClose
Lyn
Lyn
Fyn
Fyn
5-HT2A
P2Y1
5-HT2A
P2Y1
G alpha q
G alpha q
G alpha 12,13
G alpha 12,13
Fyn
Fyn
PI 3-Kinase
PI 3-Kinase
Rap1B
Rap1B
Integrin
Activation
Integrin
Activation
ProductsClose
MAPK
MAPK
ProductsClose
PLA2G4A
PLA2G4A
ProductsClose
Thromboxane Synthase
Thromboxane Synthase
Thromboxane A2
Production
Thromboxane A2
Production
Platelet Activating GPCR Signaling

Overview of Platelet Signaling Through Activating GPCRs

G protein-coupled receptors (GPCR) enahance platelet activation in response to 5-HT (serotonin), the purines ADP and ATP, prostaglandin E2, thromboxane A2, adenosine, norepinephrine, and thrombin. GPCR signaling leads to the activation of G proteins, Src familiy kinases, PKC, and PI-3 Kinase. GPCR signaling induces platelet granule release, integrin activation, and production of thromboxane A2. Pharmacologic blockade of the P2Y12 receptor is a key component of anti-thrombotic treatment.

Platelet Activating GPCR Signaling background image 1